These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 29914196)

  • 21. Ascites-derived ALDH+CD44+ tumour cell subsets endow stemness, metastasis and metabolic switch via PDK4-mediated STAT3/AKT/NF-κB/IL-8 signalling in ovarian cancer.
    Jiang YX; Siu MK; Wang JJ; Mo XT; Leung TH; Chan DW; Cheung AN; Ngan HY; Chan KK
    Br J Cancer; 2020 Jul; 123(2):275-287. PubMed ID: 32390009
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cancer stem-like cells of ovarian clear cell carcinoma are enriched in the ALDH-high population associated with an accelerated scavenging system in reactive oxygen species.
    Mizuno T; Suzuki N; Makino H; Furui T; Morii E; Aoki H; Kunisada T; Yano M; Kuji S; Hirashima Y; Arakawa A; Nishio S; Ushijima K; Ito K; Itani Y; Morishige K
    Gynecol Oncol; 2015 May; 137(2):299-305. PubMed ID: 25541259
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Histone deacetylase inhibitors stimulate dedifferentiation of human breast cancer cells through WNT/β-catenin signaling.
    Debeb BG; Lacerda L; Xu W; Larson R; Solley T; Atkinson R; Sulman EP; Ueno NT; Krishnamurthy S; Reuben JM; Buchholz TA; Woodward WA
    Stem Cells; 2012 Nov; 30(11):2366-77. PubMed ID: 22961641
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High ALDH activity defines ovarian cancer stem-like cells with enhanced invasiveness and EMT progress which are responsible for tumor invasion.
    Li Y; Chen T; Zhu J; Zhang H; Jiang H; Sun H
    Biochem Biophys Res Commun; 2018 Jan; 495(1):1081-1088. PubMed ID: 29170132
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Esophageal cancer tumorspheres involve cancer stem-like populations with elevated aldehyde dehydrogenase enzymatic activity.
    Zhang G; Ma L; Xie YK; Miao XB; Jin C
    Mol Med Rep; 2012 Sep; 6(3):519-24. PubMed ID: 22684859
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Personalized Medicine-Based Approach to Model Patterns of Chemoresistance and Tumor Recurrence Using Ovarian Cancer Stem Cell Spheroids.
    Raghavan S; Mehta P; Ward MR; Bregenzer ME; Fleck EMA; Tan L; McLean K; Buckanovich RJ; Mehta G
    Clin Cancer Res; 2017 Nov; 23(22):6934-6945. PubMed ID: 28814433
    [No Abstract]   [Full Text] [Related]  

  • 27. Characterization of aldehyde dehydrogenase 1 high ovarian cancer cells: Towards targeted stem cell therapy.
    Sharrow AC; Perkins B; Collector MI; Yu W; Simons BW; Jones RJ
    Gynecol Oncol; 2016 Aug; 142(2):341-8. PubMed ID: 27017984
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibitory effect on ovarian cancer ALDH+ stem-like cells by Disulfiram and Copper treatment through ALDH and ROS modulation.
    Guo F; Yang Z; Kulbe H; Albers AE; Sehouli J; Kaufmann AM
    Biomed Pharmacother; 2019 Oct; 118():109371. PubMed ID: 31545281
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dietary compound proanthocyanidins from Chinese bayberry (Myrica rubra Sieb. et Zucc.) leaves attenuate chemotherapy-resistant ovarian cancer stem cell traits via targeting the Wnt/β-catenin signaling pathway and inducing G1 cell cycle arrest.
    Zhang Y; Chen S; Wei C; Rankin GO; Ye X; Chen YC
    Food Funct; 2018 Jan; 9(1):525-533. PubMed ID: 29256569
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metformin targets ovarian cancer stem cells in vitro and in vivo.
    Shank JJ; Yang K; Ghannam J; Cabrera L; Johnston CJ; Reynolds RK; Buckanovich RJ
    Gynecol Oncol; 2012 Nov; 127(2):390-7. PubMed ID: 22864111
    [TBL] [Abstract][Full Text] [Related]  

  • 31. BMP-2 inhibits tumor-initiating ability in human renal cancer stem cells and induces bone formation.
    Wang L; Park P; La Marca F; Than KD; Lin CY
    J Cancer Res Clin Oncol; 2015 Jun; 141(6):1013-24. PubMed ID: 25431339
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Somatostatin signaling via SSTR1 contributes to the quiescence of colon cancer stem cells.
    Modarai SR; Opdenaker LM; Viswanathan V; Fields JZ; Boman BM
    BMC Cancer; 2016 Dec; 16(1):941. PubMed ID: 27927191
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of aldehyde dehydrogenase (ALDH) activity reduces chemotherapy and radiation resistance of stem-like ALDHhiCD44⁺ human breast cancer cells.
    Croker AK; Allan AL
    Breast Cancer Res Treat; 2012 May; 133(1):75-87. PubMed ID: 21818590
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In Ovarian Cancer Multicellular Spheroids, Platelet Releasate Promotes Growth, Expansion of ALDH+ and CD133+ Cancer Stem Cells, and Protection against the Cytotoxic Effects of Cisplatin, Carboplatin and Paclitaxel.
    Casagrande N; Borghese C; Agostini F; Durante C; Mazzucato M; Colombatti A; Aldinucci D
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33809553
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ALDH1A isozymes are markers of human melanoma stem cells and potential therapeutic targets.
    Luo Y; Dallaglio K; Chen Y; Robinson WA; Robinson SE; McCarter MD; Wang J; Gonzalez R; Thompson DC; Norris DA; Roop DR; Vasiliou V; Fujita M
    Stem Cells; 2012 Oct; 30(10):2100-13. PubMed ID: 22887839
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ursolic acid inhibits proliferation and reverses drug resistance of ovarian cancer stem cells by downregulating ABCG2 through suppressing the expression of hypoxia-inducible factor-1α in vitro.
    Wang WJ; Sui H; Qi C; Li Q; Zhang J; Wu SF; Mei MZ; Lu YY; Wan YT; Chang H; Guo PT
    Oncol Rep; 2016 Jul; 36(1):428-40. PubMed ID: 27221674
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of aldehyde dehydrogenase (ALDH) in cancer drug resistance.
    Januchowski R; Wojtowicz K; Zabel M
    Biomed Pharmacother; 2013 Sep; 67(7):669-80. PubMed ID: 23721823
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Crucial role of HMGA1 in the self-renewal and drug resistance of ovarian cancer stem cells.
    Kim DK; Seo EJ; Choi EJ; Lee SI; Kwon YW; Jang IH; Kim SC; Kim KH; Suh DS; Seong-Jang K; Lee SC; Kim JH
    Exp Mol Med; 2016 Aug; 48(8):e255. PubMed ID: 27561949
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disulfiram modulates ROS accumulation and overcomes synergistically cisplatin resistance in breast cancer cell lines.
    Yang Z; Guo F; Albers AE; Sehouli J; Kaufmann AM
    Biomed Pharmacother; 2019 May; 113():108727. PubMed ID: 30870721
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Salinomycin can effectively kill ALDH(high) stem-like cells on gastric cancer.
    Zhi QM; Chen XH; Ji J; Zhang JN; Li JF; Cai Q; Liu BY; Gu QL; Zhu ZG; Yu YY
    Biomed Pharmacother; 2011 Oct; 65(7):509-15. PubMed ID: 21996439
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.